These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 11560851)

  • 41. Menopause, complement, and hemostatic markers in women at midlife: the Study of Women's Health Across the Nation.
    El Khoudary SR; Shields KJ; Chen HY; Matthews KA
    Atherosclerosis; 2013 Nov; 231(1):54-8. PubMed ID: 24125410
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Indoxyl sulfate - the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease.
    Kamiński TW; Pawlak K; Karbowska M; Myśliwiec M; Pawlak D
    BMC Nephrol; 2017 Jan; 18(1):35. PubMed ID: 28122514
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inflammatory/hemostatic biomarkers and coronary artery calcification in midlife women of African-American and White race/ethnicity: the Study of Women's Health Across the Nation (SWAN) heart study.
    Wang NC; Matthews KA; Barinas-Mitchell EJ; Chang CC; El Khoudary SR
    Menopause; 2016 Jun; 23(6):653-61. PubMed ID: 27023861
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regular alcohol intake and fibrinolysis.
    van Golde PM; Hart HCh; Kraaijenhagen RJ; Bouma BN; van de Wiel A
    Neth J Med; 2002 Aug; 60(7):285-8. PubMed ID: 12430575
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Haemostatic risk factors for cardiovascular diseases.
    Koenig W
    Eur Heart J; 1998 Apr; 19 Suppl C():C39-43. PubMed ID: 9597424
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of simvastatin on hemostatic and fibrinolytic regulators in Type 2 diabetes mellitus.
    Ludwig S; Dharmalingam S; Erickson-Nesmith S; Ren S; Zhu F; Ma GM; Zhao R; Fenton JW; Ofosu FA; Velthuis HT; van Mierlo G; Shen GX
    Diabetes Res Clin Pract; 2005 Nov; 70(2):110-8. PubMed ID: 16188573
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Associations of von Willebrand factor, fibrin D-dimer and tissue plasminogen activator with incident coronary heart disease: British Women's Heart and Health cohort study.
    May M; Lawlor DA; Patel R; Rumley A; Lowe G; Ebrahim S
    Eur J Cardiovasc Prev Rehabil; 2007 Oct; 14(5):638-45. PubMed ID: 17925622
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism.
    Chadarevian R; Bruckert E; Leenhardt L; Giral P; Ankri A; Turpin G
    J Clin Endocrinol Metab; 2001 Feb; 86(2):732-7. PubMed ID: 11158038
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Postmenopausal oral estrogen therapy affects hemostatic factors, but does not account for reduction in the progression of subclinical atherosclerosis.
    Vigen C; Hodis HN; Chandler WL; Lobo RA; Mack WJ
    J Thromb Haemost; 2007 Jun; 5(6):1201-8. PubMed ID: 17389005
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Elevated plasma tissue plasminogen activator and anti-THP-1 antibodies are independently associated with decreased graft survival in cardiac transplant recipients.
    Warshofsky MK; Dominguez M; Eisenberg MS; Wasserman HS; Sciacca R; Wang W; Simon AD; Morse JH; Schwartz A; Anglés-Cano E; Rabbani LE
    Am J Cardiol; 2001 Jul; 88(1):30-4. PubMed ID: 11423054
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hemostatic and fibrinolytic changes are related to inflammatory conditions in patients with psoriatic arthritis--effect of different treatments.
    Di Minno MN; Iervolino S; Peluso R; Di Minno A; Ambrosino P; Scarpa R;
    J Rheumatol; 2014 Apr; 41(4):714-22. PubMed ID: 24532831
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Moderate red wine consumption and cardiovascular disease risk: beyond the "French paradox".
    Lippi G; Franchini M; Favaloro EJ; Targher G
    Semin Thromb Hemost; 2010 Feb; 36(1):59-70. PubMed ID: 20391297
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Periodontal disease and biomarkers related to cardiovascular disease.
    Joshipura KJ; Wand HC; Merchant AT; Rimm EB
    J Dent Res; 2004 Feb; 83(2):151-5. PubMed ID: 14742654
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relation of hormone-replacement therapy to measures of plasma fibrinolytic activity. Atherosclerosis Risk in Communities (ARIC) Study Investigators.
    Shahar E; Folsom AR; Salomaa VV; Stinson VL; McGovern PG; Shimakawa T; Chambless LE; Wu KK
    Circulation; 1996 Jun; 93(11):1970-5. PubMed ID: 8640970
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endothelial damage and activation of the hemostatic system during radiofrequency catheter isolation of pulmonary veins.
    Bulava A; Slavík L; Fiala M; Heinc P; Skvarilova M; Lukl J; Krcová V; Indrák K
    J Interv Card Electrophysiol; 2004 Jun; 10(3):271-9. PubMed ID: 15133367
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Which hemostatic markers add to the predictive value of conventional risk factors for coronary heart disease and ischemic stroke? The Caerphilly Study.
    Smith A; Patterson C; Yarnell J; Rumley A; Ben-Shlomo Y; Lowe G
    Circulation; 2005 Nov; 112(20):3080-7. PubMed ID: 16286603
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diurnal, seasonal, and blood-processing patterns in levels of circulating fibrinogen, fibrin D-dimer, C-reactive protein, tissue plasminogen activator, and von Willebrand factor in a 45-year-old population.
    Rudnicka AR; Rumley A; Lowe GD; Strachan DP
    Circulation; 2007 Feb; 115(8):996-1003. PubMed ID: 17296859
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The fibrinolytic system is not impaired in older men with hypertension.
    DeSouza CA; Dengel DR; Rogers MA; Cox K; Macko RF
    Hypertension; 1996 May; 27(5):1053-8. PubMed ID: 8621196
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relation of haemostatic, fibrinolytic, and rheological variables to the angiographic extent of peripheral arterial occlusive disease.
    Woodburn KR; Lowe GD; Rumley A; Love J; Pollock JG
    Int Angiol; 1995 Dec; 14(4):346-52. PubMed ID: 8708425
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome.
    Van Geet C; Proesmans W; Arnout J; Vermylen J; Declerck PJ
    Kidney Int; 1998 Oct; 54(4):1324-30. PubMed ID: 9767551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.